A big reason for Resmed’s recently announced rebrand is to reflect its increased direct-to-consumer engagement on obstructive sleep apnea and CPAP therapy. Chief Marketing Officer Katrin ...

Resmed (RMD) announced the publication of a meta-analysis in The Lancet Respiratory Medicine, demonstrating that CPAP therapy significantly ...

(RTTNews) - Resmed Inc (RMD) Wednesday said it has published a meta analysis in The Lancet Respiratory Medicine showing that CPAP therapy significantly reduces the risk of death for people with ...

This review included 30 studies to analyze the potential for prolonged life in patients who use CPAP to treat obstructive sleep apnea.

“For people with OSA, using CPAP versus not using CPAP can literally be a matter of life or death,” said Carlos Nunez, M.D., Resmed’s Chief Medical Officer. “Decades of research have shown CPAP can ...

For 35 years, Resmed has pioneered innovations in respiratory therapy, including CPAP therapy and digital health solutions. The company’s last major brand update in 2014 marked its shift to ...

CPAP therapy significantly reduces the risk of death for people with obstructive sleep apnea, according to a landmark meta-analysis supported by Resmed and published in The Lancet Respiratory Medicine ...